Ila Datar

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

Jun Wang, Miguel F. Sanmamed, Ila Datar et al. · Cell · 2018 · 883 citations

Life Sciences, Immunology, Molecular Biology +7

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Scott Gettinger, Jungmin Choi, Katherine Hastings et al. · Cancer Discovery · 2017 · 755 citations · Full text

Life Sciences, Immunology, Oncology +17

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Ila Datar, Miguel F. Sanmamed, Jun Wang et al. · Clinical Cancer Research · 2019 · 330 citations · Full text

Medicine, Immunology, Oncology +17

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non–Small Cell Lung Cancer

Franz Villarroel‐Espíndola, Xiaoqing Yu, Ila Datar et al. · Clinical Cancer Research · 2017 · 218 citations · Full text

Medicine, Immunology, Oncology +17

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Scott Gettinger, Jungmin Choi, Nikita Mani et al. · Nature Communications · 2018 · 191 citations · Full text

Life Sciences, Immunology, Oncology +17